Primary Cytoreductive Surgery: Improved Survival in Ovarian Cancer Primary Cytoreductive Surgery: Improved Survival in Ovarian Cancer
Otherwise healthy women with advanced-stage epithelial ovarian cancer who undergo primary cytoreductive surgery (PCS) have improved survival compared with those who receive neoadjuvant chemotherapy (NACT), according to Boston-based researchers.Reuters Health Information
Source: Medscape General Surgery Headlines - Category: Surgery Tags: Hematology-Oncology News Source Type: news
More News: Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | Hematology | Neoadjuvant Chemotherapy Therapy | Neoadjuvant Therapy | Ovarian Cancer | Ovaries | Surgery | Women